---
figid: PMC8045357__12985_2021_1544_Fig1_HTML
figlink: pmc/articles/PMC8045357/figure/Fig1/
number: F1
caption: a SOCS protein structure. All SOCS proteins contain a central SH2 domain,
  an amino-terminal domain of variable length and a carboxy-terminal SOCS box. The
  SH2 domain recognizes and binds phosphorylated tyrosine residues on its specific
  substrate, such as JAK proteins. The SOCS box can interact with elongin B, elongin
  C, and cullin 5, utilizes the RING-finger-domain-only protein to recruit E2 ubiquitin-transferase,
  and ubiquitinates JAKs and other cytokine receptors, ultimately targeting them for
  proteasomal degradation. b Mechanism by which the SOCS proteins suppress the JAK-STAT
  pathway and TLR signaling pathway. Cytokines or interferons bind cellular membrane
  surface receptors, which activate and phosphorylate receptor-associated JAK proteins.
  Activated JAK proteins phosphorylate receptor cytoplasmic domains, which begin to
  recruit STATs, enabling their dimerization. Next, the dimerized complex enters the
  nucleus to initiate the transcription of different target genes, including the SOCS
  gene and immune effectors. SOCS proteins negatively regulate these pathways. In
  the JAK-STAT pathway, SOCS proteins compete with recruited STAT proteins for shared
  phospho-tyrosine residues or inhibit the activity of JAKs by the KIR domain of SOCS1
  and SOCS3. Additionally, the SOCS box mediates the ubiquitination and degradation
  of bound receptor components. In the Toll-like receptor signaling pathway, SOCS1
  and SOCS3 use the SH2 region to recognize and bind tyrosine-phosphorylated Mal,
  TNF receptor-associated factor 3/6 (TRAF3/6) and IRF7 [, , ]
pmcid: PMC8045357
papertitle: The role of SOCS proteins in the development of virus- induced hepatocellular
  carcinoma.
reftext: Jinyan Xie, et al. Virol J. 2021;18:74.
pmc_ranked_result_index: '64983'
pathway_score: 0.5035867
filename: 12985_2021_1544_Fig1_HTML.jpg
figtitle: SOCS protein structure
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8045357__12985_2021_1544_Fig1_HTML.html
  '@type': Dataset
  description: a SOCS protein structure. All SOCS proteins contain a central SH2 domain,
    an amino-terminal domain of variable length and a carboxy-terminal SOCS box. The
    SH2 domain recognizes and binds phosphorylated tyrosine residues on its specific
    substrate, such as JAK proteins. The SOCS box can interact with elongin B, elongin
    C, and cullin 5, utilizes the RING-finger-domain-only protein to recruit E2 ubiquitin-transferase,
    and ubiquitinates JAKs and other cytokine receptors, ultimately targeting them
    for proteasomal degradation. b Mechanism by which the SOCS proteins suppress the
    JAK-STAT pathway and TLR signaling pathway. Cytokines or interferons bind cellular
    membrane surface receptors, which activate and phosphorylate receptor-associated
    JAK proteins. Activated JAK proteins phosphorylate receptor cytoplasmic domains,
    which begin to recruit STATs, enabling their dimerization. Next, the dimerized
    complex enters the nucleus to initiate the transcription of different target genes,
    including the SOCS gene and immune effectors. SOCS proteins negatively regulate
    these pathways. In the JAK-STAT pathway, SOCS proteins compete with recruited
    STAT proteins for shared phospho-tyrosine residues or inhibit the activity of
    JAKs by the KIR domain of SOCS1 and SOCS3. Additionally, the SOCS box mediates
    the ubiquitination and degradation of bound receptor components. In the Toll-like
    receptor signaling pathway, SOCS1 and SOCS3 use the SH2 region to recognize and
    bind tyrosine-phosphorylated Mal, TNF receptor-associated factor 3/6 (TRAF3/6)
    and IRF7 [, , ]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOCS1
  - SOCS3
  - GEM
  - CISH
  - SOCS2
  - SOCS7
  - SOCS4
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MAL
  - TRAF6
  - IRF3
  - IRF7
  - Elongin B Elongin C
genes:
- word: Socs1
  symbol: SOCS1
  source: hgnc_symbol
  hgnc_symbol: SOCS1
  entrez: '8651'
- word: SoCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: KIR
  symbol: KIR
  source: hgnc_alias_symbol
  hgnc_symbol: GEM
  entrez: '2669'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: KIR
  symbol: KIR
  source: hgnc_alias_symbol
  hgnc_symbol: GEM
  entrez: '2669'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: SOCS1
  symbol: SOCS1
  source: hgnc_symbol
  hgnc_symbol: SOCS1
  entrez: '8651'
- word: KIR
  symbol: KIR
  source: hgnc_alias_symbol
  hgnc_symbol: GEM
  entrez: '2669'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: CIS
  symbol: CIS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: SOCS2
  symbol: SOCS2
  source: hgnc_symbol
  hgnc_symbol: SOCS2
  entrez: '8835'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: SOCS7
  symbol: SOCS7
  source: hgnc_symbol
  hgnc_symbol: SOCS7
  entrez: '30837'
- word: SOCS4
  symbol: SOCS4
  source: hgnc_symbol
  hgnc_symbol: SOCS4
  entrez: '122809'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: socs
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF7
  symbol: IRF7
  source: hgnc_symbol
  hgnc_symbol: IRF7
  entrez: '3665'
- word: SOCS
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
- word: Socs
  symbol: SOCS
  source: hgnc_alias_symbol
  hgnc_symbol: CISH
  entrez: '1154'
chemicals:
- word: Elongin B Elongin C
  source: MESH
  identifier: C014396
diseases: []
figid_alias: PMC8045357__F1
redirect_from: /figures/PMC8045357__F1
figtype: Figure
---
